This indicated that CHF and BPs had inhibitory effects on the mRNA expression of RANK and RANKL, and concluded that CHF could inhibit the activity of osteoclasts and inhibit the process of bone resorption. The gene discussed is TNFRSF11A; the disease is Bartsocas-Papas syndrome 1.